Form 8-K · Current report
MetLife 8-K, filed Sep 24, 2026
- Filed
- CIK
- 0001099219
- Accession no.
- 0001099219-26-000055
Summary
MetLife disclosed preliminary, unaudited third-quarter 2026 variable investment income of at least $600 million pre-tax, ahead of its quarterly earnings release scheduled for November 4, 2026; the company said that compares with full-year 2026 guidance of approximately $1.6 billion pre-tax. MetLife cautioned that quarterly closing procedures are incomplete and actual results could differ materially.
Key points
- MetLife estimated third-quarter 2026 variable investment income at no less than $600 million pre-tax.
- Full-year 2026 guidance for variable investment income stands at approximately $1.6 billion pre-tax.
- Variable investment income includes private equity, real estate and other funds, and prepayment fees.
- MetLife's quarterly earnings release and financial supplement for the quarter ended September 30, 2026 are scheduled for November 4, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
From the filing
Item 7.01 Regulation FD Disclosure. MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose preliminary information regarding variable investment income prior to the availability of the Company’s quarterly earnings release and quarterly financial supplement for the quarter ended September 30, 2026, scheduled for release on November 4, 2026. Based on preliminary results received to date, for the quarter ended September 30, 2026, the Company estimates that its variable investment income will be at least $600 million (pre-tax), which compares to full-year 2026 guidance of approximately $1.6 billion (pre-tax). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.